PPT-Rapid Acting Insulin Analog

Majid Valizadeh MD Obesity Prevention and Treatment Research Center Research Institute for Endocrine Sciences Shahid Behesti University of Medical Sciences RIES 16 Nov 2017 Tehran Iran. Pens. Prepared by: Alison . Deux. , 4. th. year pharmacy student. Background on Diabetes. More than 9 MILLION Canadians are living with diabetes or pre-diabetes. 20 more people are diagnosed every hour. the Treatment of T1DM and T2DM. Lawrence Blonde, MD, FACP, FACE. Director of the . Ochsner. Diabetes Clinical Research Unit. Ochsner. Medical Center. New Orleans, Louisiana. Vivian . A. Fonseca, MD, FRCP. Starting insulin in general practice. Jo-Anne Manski-Nankervis. Louise Ginnivan. What we are going to cover tonight. Evidence and rationale for use of insulin in T2D and current clinical guidelines. Self monitoring, goal setting and common patient concerns. Kelly Green Boesen, Pharm D, BCPS, CDE. Type 1 DM Treatment. Insulin!. Best results is to mimic normal physiology as close as possible. Long acting insulin, meal-time coverage with rapid acting insulin. Tom Blevins MD. Texas Diabetes and Endocrinology. Austin, Texas. Stem Cell Breakthrough . In a breakthrough that signifies a move toward a cure for type 1 diabetes, Australian researchers have identified stem cells in the pancreas that can be turned into insulin-producing cells..... Moderator. Stephen Atkin, MBBS, MD, PhD. Professor of Medicine. Weill Cornell Medicine - Qatar. Education City, Qatar Foundation. Doha, Qatar. Faculty. Tim Heise, MD. Lead Scientist. Science and Administration. Starting insulin in general practice. Jo-Anne Manski-Nankervis. Louise Ginnivan. What we are going to cover tonight. Evidence and rationale for use of insulin in T2D and current clinical guidelines. Self monitoring, goal setting and common patient concerns. Rose M. Flinchum, MSEd., MS, CNS, RN, ACNS-BC, BC-ADM, CDE. Inpatient Diabetes CNS / Certified Diabetes Educator. Outpatient DSMES Quality Coordinator. Diabetes in our Practices. 2015 Statistics. 30.3 million Americans; 9.4% of the population. Sasan. . Zaeri. . (. PharmD. , PhD). Department of Pharmacology, BPUMS. . Diabetes mellitus (DM). The most common metabolic disease . Chronic hyperglycemia. Biochemical. criteria. Normal. Prediabetic. Dr. . . Ghadiri. , MD. Assistance professor of endocrinology. Shahid. . Sadoughi. . University of Medical Sciences . 2. The importance of glycemic control in minimizing complications related to diabetes has been well established in type 1 diabetes . . Type I Diabetes. School Nurse Workshop. September 2019. Stephanie Etherington, RD, CD, CDE. What is a carb?. Body’s preferred, immediate energy source. Fats and protein are more long-term. Some examples: breads, cereals, grains, pasta, rice, crackers, fruits, beans, potatoes, corn, peas, milk, yogurt, most desserts, sugar-containing beverages like juice or soda. Research Institute For Endocrine Sciences. Endocrine Research Center. Shahid Beheshti University. 04.04.1397. Outlines. Case presentation. Barriers of insulin therapy. Action-profile. Types of basal . Metformin . monotherapy. a. HbA1c <6.5%. Continue current therapy. HbA1c ≥ 6.5-8.5 %. Maximize . metformin. a. 2. Add 2. nd. tier . agent. b. HbA1c ≥10%. d. Maximize . metformin. a. Add 2. nd. Blood . ketone level. : . E. nsure adequate hydration!. 0.1-0.6 mmol/l – normal insulin with correction for high BM . 0.6-1.5 . mmol/l – 10% of total daily dose as additional rapid insulin. 1.5-3.0 mmol/l – 20% of total daily dose as additional rapid .